Keywords: USA, Biomedical industry, Competitiveness, Regulatory regimes, Milken Institute, R&D tax incentives

US leadership in global biomedical industry vulnerable to international competition

Article | 26 September 2011

The USA still holds a commanding position in the biomedical field, but countries across Europe and Asia are pursuing aggressive ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in